ProQR Therapeutics (PRQR) Current Deferred Revenue (2014 - 2026)
ProQR Therapeutics (PRQR) posted Current Deferred Revenue of $12.22 million for the quarter ended Jun 30, 2026, down 60.0% from $30.55 million a year earlier and down 39.7% from the prior quarter.
Powered by 
Analysis
ProQR Therapeutics (PRQR) Current Deferred Revenue (2014 - 2026) Analysis & Trends
As of Dec 31, 2025, ProQR Therapeutics' Current Deferred Revenue came in at $24.17 million, down 24.1% from the prior year.
- Annual Current Deferred Revenue has declined for three consecutive years, though with a five-year compound annual growth rate of 97.8% (years ended Dec 2020 to Dec 2025).
- In prior years, ProQR Therapeutics' Current Deferred Revenue was $31.85 million in the year ended Dec 31, 2024 (-33.3%), $47.78 million in the year ended Dec 31, 2023 (-30.9%), $69.11 million in the year ended Dec 31, 2022 (+297.6%) and $17.38 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Current Deferred Revenue since the quarter ended Mar 31, 2023.
- On a year-over-year basis, Current Deferred Revenue has declined in each of the last four quarters, with an average decline of 2.7% over the last eight quarters.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was the quarter ended Mar 31, 2022, with growth of 823.3%; the weakest was the quarter ended Sep 30, 2022, with a decline of 63.1%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $20.26 million (quarter ended Mar 31, 2026), $24.9 million (quarter ended Dec 31, 2025) and $28.2 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | ProQR Therapeutics | 138.02 Mn | -322.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.00 Mn |
| Mar 31, 2026 | 19.83 Mn |
| Dec 31, 2025 | 25.13 Mn |
| Sep 30, 2025 | 28.30 Mn |
| Jun 30, 2025 | 31.65 Mn |
| Mar 31, 2025 | 30.63 Mn |
| Dec 31, 2024 | 30.62 Mn |
| Sep 30, 2024 | 34.32 Mn |
| Jun 30, 2024 | 25.52 Mn |
| Mar 31, 2024 | 22.20 Mn |
| Dec 31, 2023 | 48.89 Mn |
| Sep 30, 2023 | 17.33 Mn |
| Jun 30, 2023 | 14.28 Mn |
| Mar 31, 2023 | 6.36 Mn |
| Dec 31, 2022 | 69.90 Mn |
| Sep 30, 2022 | 8.48 Mn |
| Jun 30, 2022 | 7.13 Mn |
| Mar 31, 2022 | 6.31 Mn |
| Dec 31, 2021 | 16.63 Mn |
| Sep 30, 2021 | 22.29 Mn |
API Access
ProQR Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PRQR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();